BGM·G7307E123·US·equity·Healthcare - Drug Manufacturers - Specialty & Generic-Activist
CL A ORD SHS NEW
BGM (BGM GROUP LTD) is held by 10 institutional investors as of Q1 2026. Largest holders: GEODE CAPITAL MANAGEMENT, LLC ($14,205), STATE STREET CORP ($14,076), SUSQUEHANNA INTERNATIONAL GROUP, LLP ($4,760). Net institutional sentiment: Mixed.
See how BGM's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer